Oncotarget

Research Papers:

IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65

Shruti Bhargava, Abhirami Visvanathan, Vikas Patil, Anuj Kumar, Santosh Kesari, Saumitra Das, Alangar S. Hegde, Arimappamagan Arivazhagan, Vani Santosh and Kumaravel Somasundaram _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:40469-40485. https://doi.org/10.18632/oncotarget.17118

Metrics: PDF 919 views  |   HTML 1817 views  |   ?  


Abstract

Shruti Bhargava1, Abhirami Visvanathan1, Vikas Patil1, Anuj Kumar1, Santosh Kesari2, Saumitra Das1, Alangar S. Hegde3, Arimappamagan Arivazhagan4, Vani Santosh5 and Kumaravel Somasundaram1

1Department of Microbiology and Cell Biology, Indian Institute of Science, Bangalore, India

2Department of Translational Neuro-Oncology and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John’s Health Center, Santa Monica, California, USA

3Sri Satya Sai Institute of Higher Medical Sciences, Bangalore, India

4Departments of Neurosurgery, National Institute of Mental Health and Neuro Sciences, Bangalore, India

5Departments of Neuropathology, National Institute of Mental Health and Neuro Sciences, Bangalore, India

Correspondence to:

Kumaravel Somasundaram, email: skumar@mcbl.iisc.ernet.in, ksomasundaram1@gmail.com

Keywords: IMP3, RNA binding protein, NF-κB signalling, RELA/p65, translation control

Received: December 06, 2016     Accepted: April 03, 2017     Published: April 15, 2017

ABSTRACT

The diffusely infiltrative nature of glioblastoma (GBM) makes them highly recurrent. IGF2 mRNA-binding protein 3 (IMP3), a GBM upregulated RNA binding protein, promotes glioma cell migration. An integrative bioinformatics analysis identified p65 (RELA), a subunit of NF-κB heterodimer as a target and an important mediator of IMP3 promoted glioma cell migration. IMP3 increased p65 protein levels without any change in p65 transcript levels, but promoted its polysome association. RIP-PCR demonstrated the binding of IMP3 to p65 transcript. UV crosslinking experiments with in vitro transcribed RNA confirmed the specific and direct binding of IMP3 to sites on p65 3′UTR. Further, IMP3 induced luciferase activity from p65 3′UTR reporter carrying wild type sites but not mutated sites. Exogenous overexpression of p65 from a 3′UTR-less construct rescued the reduced migration of glioma cells in IMP3 silenced condition. In addition, IMP3 silencing inhibited glioma stem-like cell maintenance and migration. The exogenous overexpression of 3′UTR-less p65 significantly alleviated the inhibition of neurosphere formation observed in IMP3 silenced glioma stem-like cells. Further, we show that IMP3 is transcriptionally activated by NF-κB pathway indicating the presence of a positive feedback loop between IMP3 and p65. This study establishes p65 as a novel target of IMP3 in increasing glioma cell migration and underscores the significance of IMP3-p65 feedback loop for therapeutic targeting in GBM.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 17118